Trial Profile
Ziprasidone for the treatment of refractory social anxiety disorder [social phobia]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2014
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Sertraline
- Indications Social phobia
- Focus Therapeutic Use
- 13 Aug 2008 Planned end date for this trial is now 1 Jan 2008 as reported by ClinicalTrials.gov
- 13 Aug 2008 Status changed from recruiting to completed.as reported by ClinicalTrials.gov
- 06 Nov 2005 New trial record.